Daehan New Pharm Co. Ltd (054670) — Financial Flexibility Index
Daehan New Pharm Co. Ltd (054670) has a Financial Flexibility Index of 0.13x as of September 2025. Free cash flow of ₩15.96 Billion (operating CF ₩4.43 Billion minus capex ₩11.53 Billion) represents 0% of total liabilities (₩122.10 Billion). Also explore 054670 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Daehan New Pharm Co. Ltd Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Daehan New Pharm Co. Ltd across 11 annual periods. Check Daehan New Pharm Co. Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Daehan New Pharm Co. Ltd (2014–2024)
Year-by-year free cash flow to debt coverage for Daehan New Pharm Co. Ltd. For the full company profile including market capitalisation, see 054670 market cap overview.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.56x | ₩53.20 Billion | ₩18.95 Billion | ₩95.85 Billion | ▲ +66.7% |
| 2023 | 0.33x | ₩22.50 Billion | ₩12.57 Billion | ₩67.57 Billion | ▲ +24.4% |
| 2022 | 0.27x | ₩17.77 Billion | ₩14.25 Billion | ₩66.40 Billion | ▼ -25.9% |
| 2021 | 0.36x | ₩27.14 Billion | ₩16.58 Billion | ₩75.18 Billion | ▲ +19.1% |
| 2020 | 0.30x | ₩23.01 Billion | ₩13.55 Billion | ₩75.95 Billion | ▼ -36.7% |
| 2019 | 0.48x | ₩31.97 Billion | ₩22.89 Billion | ₩66.84 Billion | ▲ +41.4% |
| 2018 | 0.34x | ₩22.21 Billion | ₩20.47 Billion | ₩65.66 Billion | ▲ +2122.9% |
| 2017 | -0.02x | ₩-1.17 Billion | ₩-2.42 Billion | ₩70.09 Billion | ▼ -107.5% |
| 2016 | 0.22x | ₩13.32 Billion | ₩8.75 Billion | ₩59.52 Billion | ▲ +6.3% |
| 2015 | 0.21x | ₩11.67 Billion | ₩7.80 Billion | ₩55.43 Billion | ▼ -28.7% |
| 2014 | 0.30x | ₩16.71 Billion | ₩10.02 Billion | ₩56.58 Billion | — |